Euro
USD
British Pound
NULL
Product Description
Puumala Virus Glycoprotein Antibody | 7691 | ProSci
Host: Rabbit
Reactivity: Virus
Homology: N/A
Immunogen: Puumala virus glycoprotein antibody was raised against a 19 amino acid peptide near the amino terminus of the Puumala virus glycoprotein.
The immunogen is located within amino acids 90 - 140 of Puumala Virus Glycoprotein.
Research Area: Infectious Disease
Tested Application: E
Application: Puumala virus glycoprotein antibody can detect 10ng Puumala virus glycoprotein peptide in ELISA at 1 μg/ml.
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: Puumala virus glycoprotein antibody is affinity chromatography purified via peptide column.
Clonality: Polyclonal
Clone: N/A
Isotype: IgG
Conjugate: Unconjugated
Physical State: Liquid
Buffer: Puumala virus glycoprotein antibody is supplied in PBS containing 0.02% sodium azide.
Concentration: 1 mg/mL
Storage Condition: Puumala virus glycoprotein antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year.
Alternate Name: Puumala Virus Glycoprotein Antibody: Envelope glycoprotein, M polyprotein, GP
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: Puumala virus (PUUV) is a rodent-borne hantavirus of the family Bunyaviridae, an enveloped, negative-sense RNA viruses with a tripartite genome that can cause hantavirus pulmonary syndrome (HPS) and is highly homologous to the protype hantavirus Hantaan virus (1) . Like other hantaviruses, the PUUV glycoprotein is synthesized as a precursor that is posttranslationally processed into two glycoproteins G1 (Gn) and G2 (Gc) . These glycoproteins interact with the PUUV nucleocapsid (NP) protein through their cytoplasmic tail, and this association has been suggested to be crucial to the binding of the ribonucleoprotein of the PUUV and the assembly of the virus particle (2) .
